Fig. 3
From: The dual role of calnexin on malignant progression and tumor microenvironment in glioma
Effect of CANX silencing on malignant progression of glioma. (a) CCK-8 assay was used to detect the viability change of GBM cells after CANX silencing. (b) GBM cell invasion ability was assessed by transwell assay. (c) Wound healing assay was used to evaluate cell migration ability after CANX silencing at 24 and 48 h. (d) Colony formation assay was used to evaluate cell proliferation ability. (e) The change of apoptosis ability in GBM cells were detected by flow cytometry after CANX silencing.
